Viés de alta
Morpheus.Network Falling Wedge Breakout

Morpheus.Network (MRPHBTC) just broke out of a falling wedge, this can lead to nice gains.
On the chart above you can find our "main target", with over 80% of potential profits.
The stop-loss is also marked.
You can always set your own stop-loss based on your risk tolerance.
Namaste.
On the chart above you can find our "main target", with over 80% of potential profits.
The stop-loss is also marked.
You can always set your own stop-loss based on your risk tolerance.
Namaste.
Nota
This one is going perfectly... Prepare for profits.Nota
TARGET:1) 0.00001515 |Hit 18-Apr. (+39%)
2) 0.00001717 |Hit 22-Apr. (+58%)
3) 0.00001919 |Hit 22-Apr. (+76%)
4) 0.00002300 |Hit 22-Apr. (+111%)
Nota
-TARGET:
1) 0.00001515 |Hit 18-Apr. (+39%)
2) 0.00001717 |Hit 22-Apr. (+58%)
3) 0.00001919 |Hit 22-Apr. (+76%)
4) 0.00002300 |Hit 22-Apr. (+111%)
5) 0.00002700 |Hit 23-Apr. (+148%)
6) 0.00003200 |Hit 23-May (+194%)
7) 0.00003600 |Hit 23-May (+231%)
8) 0.00004040 |Hit 23-May (+271%)
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Aviso legal
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Aviso legal
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.